General Information of the Compound
Compound ID
CP0427349
Compound Name
N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)pyridine-4-carboxamide
    Show/Hide
Structure
Formula
C17H11ClN4O
Molecular Weight
322.755
Canonical SMILES
Clc1cc(NC(=O)c2ccncc2)c2[nH]c3cnccc3c2c1
    Show/Hide
InChI
InChI=1S/C17H11ClN4O/c18-11-7-13-12-3-6-20-9-15(12)21-16(13)14(8-11)22-17(23)10-1-4-19-5-2-10/h1-9,21H,(H,22,23)
    Show/Hide
InChIKey
INRHIERIYYTNDP-UHFFFAOYSA-N
Physicochemical Property
logP
4.0168
Rotatable Bonds
2
Heavy Atom Count
23
Polar Areas
70.67
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10448840
SID: 15470112
ChEMBL ID
CHEMBL80843
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01239, Inhibitor of nuclear factor kappa-B kinase subunit alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS